Form 8-K - Current report:
SEC Accession No. 0001193805-25-000820
Filing Date
2025-06-06
Accepted
2025-06-06 16:05:57
Documents
12
Period of Report
2025-06-06
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 e664613_8k-arct.htm   iXBRL 8-K 46578
  Complete submission text file 0001193805-25-000820.txt   212742

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE arct-20250606.xsd EX-101.SCH 3020
3 XBRL LABEL FILE arct-20250606_lab.xml EX-101.LAB 34239
4 XBRL PRESENTATION FILE arct-20250606_pre.xml EX-101.PRE 22362
14 EXTRACTED XBRL INSTANCE DOCUMENT e664613_8k-arct_htm.xml XML 3712
Mailing Address 10628 SCIENCE CENTER DRIVE SUITE 250 SAN DIEGO CA 92121
Business Address 10628 SCIENCE CENTER DRIVE SUITE 250 SAN DIEGO CA 92121 8589002660
Arcturus Therapeutics Holdings Inc. (Filer) CIK: 0001768224 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38942 | Film No.: 251030606
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)